Biopharma dealmaking in 2020

被引：1

|

作者：

Giglio, Patricia ^{[1
]}

Micklus, Amanda ^{[1
]}

机构：

[1] Informa, New York, NY 10158 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2021年 / 20卷 / 02期

关键词：

D O I：

10.1038/d41573-021-00015-9

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：95 / 96

页数：2

相关论文

共 50 条

[31] BioPharma operations excellence
London, A
BIOPHARM INTERNATIONAL, 2005, 18 (09) : 75 - 76
[32] Biopharma in Piedmont, Italy
Sakariassen, KS
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (06) : 519 - 519
[33] Automating Biopharma Manufacturing
Markarian, Jennifer
BIOPHARM INTERNATIONAL, 2022, 35 (07) : 10 - 14
[34] Biopharma in Piedmont, Italy
Kjell S. Sakariassen
Nature Reviews Drug Discovery, 2005, 4 : 519 - 519
[35] Cross Contamination in Biopharma
Haigney, Susan
Ward, John
BIOPHARM INTERNATIONAL, 2016, 29 (12) : 54 - 55
[36] BioPharma operations excellence
London, A
BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2003, 16 (08): : 18 - 19
[37] Pharmaceutical Dealmaking Broadens its Partnering Base
Burrill, G. Steven
BIOPHARM INTERNATIONAL, 2012, 25 (07) : 16 - 17
[38] Pore Space Dealmaking Picks Up Momentum
Boschee, Pam
JPT, Journal of Petroleum Technology, 2023, 75 (03): : 10 - 11
[39] Stability Testing in Biopharma
Chotou, Stella-Christiana
BIOPHARM INTERNATIONAL, 2015, 28 (09) : 52 - 55
[40] Biopharma 5.0 Restoring the Human Element: Whereas Biopharma 4.0 prioritizes productivity, Biopharma 5.0 emphasizes environmental and social sustainability
Macdonald, Gareth John
Genetic Engineering and Biotechnology News, 2024, 44 (10): : 38 - 41

← 1 2 3 4 5 →